AngioDynamics Earns FDA Clearance for Ports With BioFlo Technology to Reduce Catheter-Related Thrombus

AngioDynamics announced that the FDA has granted 510(k) clearance to Navilyst Medical for its BioFlo Port with Endexo technology designed to reduce the accumulation of catheter-related thrombus on, and in, the port catheter.
DeviceSpace